• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类增强药物的社会学研究:微剂量致幻剂案例。

Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.

机构信息

Public Health Institute, Liverpool John Moores University, UK.

出版信息

Int J Drug Policy. 2021 Sep;95:103099. doi: 10.1016/j.drugpo.2020.103099. Epub 2021 Jan 29.

DOI:10.1016/j.drugpo.2020.103099
PMID:33518382
Abstract

Microdosing psychedelics is the regular use of sub-perceptive threshold doses of substances such as lysergic acid diethylamide (LSD) and psilocybin ('magic') mushrooms. The phenomenon has attracted increasing public and scientific attention in numerous countries in recent years. This commentary looks at microdosing psychedelics as an emerging facet of human enhancement through drugs. After presenting a narrative based on a multidisciplinary body of literature on human enhancement drugs and microdosing, the commentary maps out directions for further sociological studies of the phenomenon as well as outlining the different fields such research can contribute to.

摘要

微剂量使用迷幻剂是指定期使用低于感知阈值的致幻剂,如麦角酸二乙酰胺(LSD)和裸盖菇素蘑菇(“魔法”蘑菇)。近年来,这一现象在许多国家引起了越来越多的公众和科学界的关注。本评论将微剂量使用迷幻剂视为通过药物实现人类增强的一个新方面。在基于人类增强药物和微剂量的多学科文献的叙述之后,本评论为进一步研究这一现象的社会学研究指明了方向,并概述了此类研究可以做出贡献的不同领域。

相似文献

1
Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.人类增强药物的社会学研究:微剂量致幻剂案例。
Int J Drug Policy. 2021 Sep;95:103099. doi: 10.1016/j.drugpo.2020.103099. Epub 2021 Jan 29.
2
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
3
Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.微剂量服用麦角酸二乙酰胺和裸盖菇素的副作用:对潜在生理和精神结果的系统评价
Neuropharmacology. 2025 Jun 15;271:110402. doi: 10.1016/j.neuropharm.2025.110402. Epub 2025 Mar 7.
4
Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.饮食失调或进食紊乱个体使用迷幻剂的情况:国际MED-FED调查结果
J Eat Disord. 2025 Jul 24;13(1):152. doi: 10.1186/s40337-025-01328-5.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Drug-drug interactions involving classic psychedelics: A systematic review.涉及经典迷幻剂的药物-药物相互作用:系统评价。
J Psychopharmacol. 2024 Jan;38(1):3-18. doi: 10.1177/02698811231211219. Epub 2023 Nov 20.
7
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.在一项随机对照试验中,通过丘脑-皮质模型捕获的小剂量麦角酸二乙酰胺(LSD)对长期增强作用的调节。
BMC Neurosci. 2024 Feb 5;25(1):7. doi: 10.1186/s12868-024-00844-5.
8
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.迷幻剂在治疗物质使用障碍中的治疗潜力:临床试验综述
Medicina (Kaunas). 2025 Feb 6;61(2):278. doi: 10.3390/medicina61020278.
9
Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?小剂量迷幻剂的潜在治疗效果:微剂量用药在精神病学中有作用吗?
Int Rev Neurobiol. 2025;181:231-268. doi: 10.1016/bs.irn.2025.03.002. Epub 2025 Apr 2.
10
The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.迷幻药对酒精使用障碍患者的影响:系统评价和荟萃分析。
Curr Med Res Opin. 2024 Feb;40(2):293-302. doi: 10.1080/03007995.2023.2296968. Epub 2024 Jan 24.

引用本文的文献

1
Unlocking the self: Can microdosing psychedelics make one feel more authentic?释放自我:微剂量使用迷幻药能让人感觉更真实吗?
Nordisk Alkohol Nark. 2024 Apr;41(2):142-155. doi: 10.1177/14550725231175353. Epub 2023 May 24.
2
Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.微量使用迷幻药与心脏纤维化和瓣膜病的风险:与已知的心脏毒素比较。
J Psychopharmacol. 2024 Mar;38(3):217-224. doi: 10.1177/02698811231225609. Epub 2024 Jan 12.